InsidersTradesSigma
Track the 아리바이오LAB share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Market capitalisation: €494.6m. The latest transaction was disclosed on 15 July 2026 (Other). Among the most active insiders: 아리바이오LAB. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
AribioLAB is a company listed on the XKRX market, specializing in the development of biopharmaceutical solutions. It focuses on research and innovation in the healthcare sector.